ELV vs VNDA · P/E 18, rev $199.13B vs rev $102.2M
Elevance Health Inc (ELV) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the ELV and VNDA stock pages for the full models.
Not investment advice.